Hakan Goker

Hakan Goker

Managing Director at M Ventures, Head of Biotechnology Investments, Amsterdam, The Netherlands

Hakan Goker is the Managing Director, and heads the Biotechnology team responsible for Healthcare and Life Sciences investments of M Ventures, the strategic venture capital fund of Merck KGaA, Darmstadt, Germany. A venture investor for 15 years, starting at Atlas Venture, continuing at Aescap Venture, joining M Ventures in 2013, Hakan has been instrumental in the formation, management and business strategy of multiple companies globally throughout his tenure including Artios Pharma, Orphazyme, f-Star, Bicycle Therapeutics, Nimbus Discovery, Storm Therapeutics, and Ribometrix.

M Ventures’ mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From the headquarters in Amsterdam, Netherlands, and offices in the US and Israel, M Ventures invests globally in transformational ideas driven by great entrepreneurs, takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. M Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

The Worldwide Business School for Life Sciences

Barcelona Campus

Barcelona Scientific Park
Baldiri Reixac St., 4-8, 08028, Barcelona

Entity Associated to 

Cambridge Campus

The Bradfield Centre, Cambridge Science Park
184, Milton Road, CB4 0GA, Cambridge

Entity based at 


Mexico Campus

World Trade Center CDMX, Montecito 38,
Col. Nápoles, 03810, Mexico City

Entity based at 

In educational collaboration agreement for the development of the Global MBAs

Biotechnology Business Institute ©2022 All Rights Reserved | Wolke SAS